Navigation Links
Drs Sandy Chang and Kathleen Collins Join LIFE LENGTH®'s Scientific Advisory Board
Date:3/6/2012

MADRID, March 6, 2012 /PRNewswire/ --

Life Length, the world's leading telomere testing and services company, announced that Drs Sandy Chang and Kathleen Collins have joined its Scientific Advisory Board ("SAB").

Stephen J. Matlin, CEO, Life Length, noted, "We are delighted to welcome these world-renowned telomere and telomerase experts to Life Length's SAB. They will help advance our global leadership.  Dr Chang is especially well known for pioneering work in understanding how telomere binding proteins protect chromosome ends from engaging DNA damage response.  Dr. Collins has led the way in reconstituting recombinant telomerase complexes and demonstrating the significance of individual differences in telomere length on human health span."

Dr Sandy Chang is currently Associate Professor and Associate Director of Molecular Diagnostics, Department of Laboratory Medicine, Yale University School of Medicine, having received numerous awards including those from the Howard Hughes Medical Institute, the Ellison Medical Foundation, the Sidney Kimmel Foundation for Cancer Research, and the Ellis Benson Award from the Academy of Clinical Laboratory Physicians and Scientists.

Dr Kathleen Collins is Professor of Molecular and Cell Biology at the University of California, Berkeley.  Her awards include a Burroughs Wellcome Fund Award in Pharmacological Sciences, Early Career Life Scientist Award from The American Society for Cell Biology, and University of California Berkeley Miller Professorship.

In addition to Drs Chang and Collins, the Life Length SAB includes Dr María A. Blasco, Director, Spanish National Cancer Research Centre; Dr Jerry W. Shay, Vice Chairman, Department of Cell Biology, The University of Texas Southwestern Medical Center, Dallas; Dr William H. Andrews, founder, President and CEO, Sierra Sciences, that focuses exclusively on finding drugs that will transiently induce expression of endogenous telomerase in human cells; and Dr Mark Rosenberg, MD, President, The Institute for Healthy Aging.

About Life Length

Life Length, a life sciences company founded in 2010 to commercially exploit Telomere Analysis Technology (TAT) as a spin-off of the Spanish National Cancer Research Centre, is the only company in world able to individually measure critically short telomeres, the crucial measure for cell senescence, aging and age-related diseases. Life Length provides testing services to pharmaceutical and biotech industries for drug R&D and clinical trials, as well as to the general public through physicians and clinics interested in telomere indicators of biological age and overall health.  http://www.lifelength.com


'/>"/>
SOURCE Life Length
Copyright©2010 PR Newswire.
All rights reserved

Related medicine technology :

1. Professor Dr. Alexander (Sandy) Lawson is Awarded the 2011 Herman Skolnik Award
2. Media Alert: Elekta to Present $50,000 to Miami-Based Sandy B. Muller Breast Cancer Foundation at ASTRO Annual Meeting
3. Thomson Scientific Publishes The Ones to Watch - A Quarterly Review of Phase Changes in the Pharmaceutical Pipeline
4. Getty Images Celebrates Conclusion of Change Me Imagery Forum
5. Researcher Investigates Disparities in Doctor-Patient Information Exchange During Clinical Trial Offers
6. Wedgewood Introduces Refresh(TM) Exchange-Program: Free Exchange of Expired Veterinary Compounded Medications Solves Key Industry Problem
7. Micromet Announces Changes in Management Team
8. Cancer Cure Coalition Proposes Major Changes at the FDA
9. World Renowned Cancer Centers Implore Americans to Donate $1 to Make Change and Accelerate Cancer Research
10. Soliris(R) Improved Fatigue Independent of Changes in Anemia in Patients with PNH by Controlling Hemolysis
11. Silence Therapeutics Announces Board Changes
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/24/2016)... CHAPEL HILL, N.C. , June 24, 2016 ... in healthcare decisions and regulators/payers have placed more ... this new environment, patient support programs in the ... support for patients, medications. Consequently, pharmaceutical companies are ... to ensure they are providing products and services ...
(Date:6/24/2016)... 24, 2016  Global Blood Therapeutics, Inc. (GBT) (NASDAQ: ... novel therapeutics for the treatment of grievous blood-based ... closing of its previously announced underwritten public offering ... public offering price of $18.75 per share. All ... by GBT. GBT estimates net proceeds from the ...
(Date:6/24/2016)... , June 24, 2016 ... Markets has announced the addition of the " ... offering. This ... and provides an updated review, including its applications in ... the total market, which includes three main industries: pharmaceutical ...
Breaking Medicine Technology:
(Date:6/27/2016)... ... June 27, 2016 , ... TherapySites, ... its affiliation with Tennessee Counseling Association. This new relationship allows TherapySites ... Tennessee Counseling Association, adding exclusive benefits and promotional offers. , "TCA is extremely ...
(Date:6/26/2016)... ... , ... Quality metrics are proliferating in cancer care, and are derived from ... of the beholder, according to experts who offered insights and commentary in the current ... For the full issue, click here . , For the American Society of ...
(Date:6/26/2016)... ... ... a legally blind and certified personal trainer is helping to develop a weight loss fitness ... to fix the two major problems leading the fitness industry today:, , ... They don’t eliminate all the reasons people quit their exercise program ...
(Date:6/25/2016)... ... ... The temporary closing of Bruton Memorial Library on June 21 due to a possible lice ... overlooked aspect of head lice: the parasite’s ability to live away from a human host, ... a necessary one in the event that lice have simply gotten out of control. , ...
(Date:6/25/2016)... , ... June 25, 2016 , ... ... and non-athletes recover from injury. Recently, he has implemented orthobiologic procedures as a ... area —Johnson is one of the first doctors to perform the treatment. Orthobiologics ...
Breaking Medicine News(10 mins):